Blue Star Limited (BLUESTARCO)
Please find Enclosed.
AI summary
- Q4FY26 consolidated revenue grew 1.3% y-y to Rs 4,072 Cr; EBITDA margin improved to 8% from 7%
- FY26 revenue grew 3.6% to Rs 12,402 Cr; EBITDA margin at 7.5% vs 7.3% in FY25; PAT declined 4.3% to Rs 527.3 Cr
- Electromechanical projects segment revenue up 12.8% in FY26; order inflow up 35.7% in Q4
- Unitary Products segment revenue declined 5.1% in FY26; room AC demand picked up in March; margins improved in Q4
- Data center MEP business ~Rs 1,000 Cr revenue, expected to more than double in 3 years
- FY27 outlook cautious; summer season started mid-April; margin pressures expected due to commodity and geopolitical risks
- Price increases of ~8% taken so far in RAC; total ~13% needed to cover cost inflation; margin target 8-8.5% for FY27
- Capex guidance Rs 250-350 Cr for FY27; focus on cost management and market share growth
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 BLUESTARCO — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add BLUESTARCO to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Blue Star Limited
Important.
The summary above is generated automatically from Blue Star Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.